Home/Filings/4/0001415889-22-012843
4//SEC Filing

Greenfield Andrew J 4

Accession 0001415889-22-012843

CIK 0000815094other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:05 PM ET

Size

17.9 KB

Accession

0001415889-22-012843

Insider Transaction Report

Form 4
Period: 2022-12-16
Greenfield Andrew J
VP Healthcare Solutions
Transactions
  • Award

    Common Stock, $.01 par value

    2022-12-16+1415,977 total
Holdings
  • Stock Option (right to buy)

    Exercise: $266.39From: 2020-05-30Exp: 2029-05-30Common Stock (0 underlying)
    7,000
  • Stock Option (right to buy)

    Exercise: $223.90From: 2021-05-29Exp: 2030-05-29Common Stock (0 underlying)
    4,896
  • Stock Option (right to buy)

    Exercise: $99.62From: 2017-05-24Exp: 2026-05-24Common Stock (0 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $134.51From: 2018-05-15Exp: 2027-05-15Common Stock (0 underlying)
    6,500
  • Stock Option (right to buy)

    Exercise: $381.97From: 2019-05-16Exp: 2028-05-16Common Stock (0 underlying)
    4,000
  • Stock Option (right to buy)

    Exercise: $283.88From: 2022-05-25Exp: 2031-05-25Common Stock (0 underlying)
    2,868
Footnotes (3)
  • [F1]These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)
  • [F2]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  • [F3]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.

Issuer

ABIOMED INC

CIK 0000815094

Entity typeother

Related Parties

1
  • filerCIK 0001372715

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:05 PM ET
Size
17.9 KB